Dr. Conti received degree in Biology in 2001, PhD in Pharmacology and Clinical and Experimental Medicine in 2010 and Post degree specialization in Pharmacology in 2011. Her main research fields are Genetics and Pharmacogenetics, Toxicology and Appropriateness of pharmacological treatment, Oxidative Stress, Aging, Physical Exercise in Health and Disease, Cardiovascular and Respiratory diseases. Dr. Conti is a permanent scientific contributor of Pharmacogenetic Newsletter of Pharmacology Italian Society (SIF) of which she is a member. She has published papers in peer-reviewed journal and is referee of international peer review journal (European Journal of Pharmacology, World Journal of Medicine and Medical Science Research, Journal of Clinical Endocrinology & Metabolism).
M. Elahi University of Southampton Southampton (United Kingdom)
Prof. Elahi, earned B.Sc. M.B.B.S. and M.Sc. degrees from the University of Glasgow, and a Ph.D. from the University of Southampton, UK. He brings expertise and skill in general adult cardiac surgery, thoracic surgery, complex congenital/ paediatric cardiac surgery, etc. He also established an independent, non-governmental, not-for-profit organization named CardiacEye International Foundation (www.cardiaceye.com) to provide free and affordable adult and pediatric heart surgeries around the world in underdeveloped and developing countries. His work in basic and clinical work has culminated over 170 peer-reviewed publications in scientific journals of repute.
X. Qi General Hospital of Northern Theater Command Shenyang (China)
Dr. Qi’s major research interests are the clinical researches in the etiology, diagnosis and management of liver cirrhosis, portal hypertension (especially portal vein thrombosis and Budd-Chiari syndrome), and hepatocellular carcinoma. His major work was published in the Nature Reviews Gastroenterology and Hepatology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Thrombosis and Haemostasis, American Journal of Medicine, etc. He served as an Associate Editor of Annals of Hepatology and a lead guest editor in two special issues in two SCI journals, Gastroenterology Research and Practice and BioMed Research International. He also served as a peer-reviewer in more than 30 SCI journals.
P. Scicchitano University of Bari Bari (Italy)
Dr. Pietro Scicchitano obtained his Degree in Medicine and Surgery in 2008 discussing a thesis entitled, “Evaluation of cardiovascular risk in patients suffering from Polycystic Ovary Syndrome”. Additionally, he also has a Degree of Instructor in Basic Life Support and Defibrillation (obtained in 2007). He is currently affiliated with University of Bari, Bari, Italy. His skills and expertise mainly lie in the subject areas of Hypertension, Heart Failure, Inflammation, Insulin Resistance, Atherosclerosis, Diabetes, Echocardiography, Myocardial Infarction, Blood Pressure, Pharmacology, Cardiology, Biomarkers, etc. Dr. Scicchitano is an author/co-author of over 110 full articles in international scientific journals, has 170 abstracts published in international journals, and has also published 4 chapters in scientific books.
Garry X. Shen University of Manitoba Winnipeg, MB (Canada)
Dr. Shen is the Professor in the Departments of Internal Medicine in the University of Manitoba. He graduated and received Master and Doctorial degrees from Shanghai Jiaotong University School of Medicine, and worked as physician in Shanghai Institute of Hypertension and Department of Cardiology in Shanghai Ruijin Hospital. He received postdoctoral training in University of Iowa, Cleveland Clinical Foundation, and University of Alberta. He has joined the Section of Endocrinology, Department of Internal Medicine, Faculty of Medicine in University of Manitoba since 1991 and promoted as Professor in 2006. His research program aims to mechanism and management of for diabetic cardiovascular complications and gestational diabetes. He published >100 peer reviewed papers and received a number of national and international awards and recognitions including Editor-in-Chief of Cardiovascular and Hematological Disorders-Drug Target, Advisory Professor in Shanghai Jiaotong University School of Medicine, and Councilor of Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology.